Extension for Community Healthcare Outcomes (ECHO) Autism Diagnostic Study in Primary Care Setting

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

February 4, 2024

Study Completion Date

February 4, 2024

Conditions
Children18-72 Months With a Suspicion Autistic Disorder
Interventions
DEVICE

Canvas Dx

Canvas Dx is intended for use by healthcare providers as an aid in the diagnosis of autism spectrum disorder (ASD) for patients ages 18 months through 72 months who are at risk for developmental delay based on concerns of a parent, caregiver, or healthcare provider. The device is not intended for use as a stand-alone diagnostic device but as an adjunct to the diagnostic process. The device is for prescription use only (Rx only)

Trial Locations (1)

65201

ECHO Autism, Columbia

All Listed Sponsors
collaborator

University of Missouri-Columbia

OTHER

lead

Cognoa, Inc.

INDUSTRY